8-K filing — Cytek Biosciences, Inc. (CTKB)
Filed: 2026-09-29 AccNo: 0001193125-26-407330 Size: 347 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
Stocks · News reference
US stock futures higher with Nasdaq 100 up 150 points. Ryanair (RYAAY) shares fall after weak Q1 results. Other stocks declining in pre-market.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-09-29 AccNo: 0001193125-26-407330 Size: 347 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
Cytek Biosciences, Inc. ("Cytek Biosciences," "Cytek," or the "Company") (NASDAQ:CTKB), a leading cell analysis solutions company, today announced that a jury in the United States District Court
A class action lawsuit has been filed against HDFC Bank Limited for allegedly making materially false statements and failing to disclose that the company camouflaged payments as marketing spend to pay higher interest to a state firm. The scheme was allegedly approved by senior management and likely violated regulations. Investors who purchased HDB securities between July 17, 2023 and May 26, 2026 can apply to be lead plaintiff by October 13, 2026.